Oncology and Hematology

Episodes 241-256 of 390

HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
MinuteCE®
HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
1.25 program credits
- Yelena Janjigian, MD
1.25 program credits
Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for First-Line G/GEJ Cancer Therapy
Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for First-Line G/GEJ Cancer Therapy
MinuteCE®
Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for First-Line G/GEJ Cancer Therapy
1.25 program credits
- Yelena Janjigian, MD
- Samuel J. Klempner, MD
1.25 program credits
Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
MinuteCE®
Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
1.25 program credits
- Yelena Janjigian, MD
- Samuel J. Klempner, MD
1.25 program credits
Incorporating Data Into Practice: Late-Breaking Highlights on G/GEJ Cancers From the 2024 GI Congress
Incorporating Data Into Practice: Late-Breaking Highlights on G/GEJ Cancers From the 2024 GI Congress
MinuteCE®
Incorporating Data Into Practice: Late-Breaking Highlights on G/GEJ Cancers From the 2024 GI Congress
1.25 program credits
- Yelena Janjigian, MD
1.25 program credits
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Project Oncology®
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
- Jessica E. Hawley M.D. M.S.
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
- Jessica E. Hawley M.D. M.S.
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
- Neal Shore, MD
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Project Oncology®
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
- Daniel Kwon, MD
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Project Oncology®
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®
Addressing Health Equity in Genitourinary Cancer Clinical Trials
An Exploration of Current and Emerging Therapies for mCRPC
An Exploration of Current and Emerging Therapies for mCRPC
Project Oncology®
An Exploration of Current and Emerging Therapies for mCRPC
Inflammatory Breast Cancer: A New Scoring System Proposed
Inflammatory Breast Cancer: A New Scoring System Proposed
Project Oncology®
Inflammatory Breast Cancer: A New Scoring System Proposed
- Filipa Lynce, MD
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Project Oncology®
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
- Filipa Lynce, MD
A Look at What’s New in Invasive Lobular Carcinoma
A Look at What’s New in Invasive Lobular Carcinoma
Project Oncology®
A Look at What’s New in Invasive Lobular Carcinoma
- Pavani Chalasani, MD, MPH
- Jason A. Mouabbi, MD
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Project Oncology®
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Project Oncology®
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care